Table of contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Screening and Adoption Trends (2023), by Region
5.2 Technological Trends & Advancements in MCED (2023-2032)
5.3 Patient & Physician Acceptance Trends (2023-2032)
5.4 Healthcare Spending and Reimbursement Trends (2023 & Forecast 2024-2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Multi-Cancer Early Detection Market Segmentation, by Type
-
- Chapter Overview
7.2 Liquid Biopsy
7.2.1 Liquid Biopsy Market Trends Analysis (2020-2032)
7.2.2 Liquid Biopsy Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Gene Panel, LDT, & Others
7.3.1 Gene Panel, LDT, & Others Market Trends Analysis (2020-2032)
7.3.2 Gene Panel, LDT, & Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Multi-Cancer Early Detection Market Segmentation, by End Use
-
- Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Diagnostic Laboratories
8.3.1 Diagnostic Laboratories Market Trends Analysis (2020-2032)
8.3.2 Diagnostic Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Multi-Cancer Early Detection Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.4 North America Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.5.2 USA Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.6.2 Canada Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.6.2 France Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Multi-Cancer Early Detection Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 China Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 India Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 Japan Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.9.2 Australia Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Multi-Cancer Early Detection Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Multi-Cancer Early Detection Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.4 Africa Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Multi-Cancer Early Detection Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.4 Latin America Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Multi-Cancer Early Detection Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Multi-Cancer Early Detection Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Illumina, Inc.
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 GRAIL, Inc.
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Exact Sciences Corporation
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 FOUNDATION MEDICINE, INC.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 AnchorDx
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Guardant Health
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Burning Rock Biotech Limited
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 GENECAST
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Beijing Lyman Juntai International Medical Technology Development Co.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Freenome Holdings, Inc.
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
